Physician
Ward, Carrie
Ward, Carrie was paid $0.00 by Medicaid between Apr 2022 and Dec 2024, across 97 billing codes. Its largest line is 82728, — 0% of everything it billed.
33Billing provider infoWARD, CARRIE
LA CANADA, CA 91011
LA CANADA, CA 91011
33aNPI1407116890assigned 05/21/2012
33bProvider typeInternal Medicine Physician
28Total paid$0.00
24GClaims41,625
24DCodes billed97
24AFirst – last monthApr 2022 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#2,431 of 2,679
Median peer was paid$13K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 3,863 | $0.00 | |
| 2023 | 11,927 | $0.00 | |
| 2024incomplete | 25,835 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82728 | 0% | 341 | 338 | $0.00 | |
| 87340 | 0% | 117 | 116 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 769 | 570 | $0.00 |
| 3052F | 0% | 40 | 40 | $0.00 | |
| 86141 | 0% | 332 | 322 | $0.00 | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 0% | 293 | 289 | $0.00 |
| 3079F | 0% | 266 | 262 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 766 | 718 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 208 | 207 | $0.00 |
| 87522 | Neg quan hep c or qual rna | 0% | 262 | 260 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 878 | 870 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 3,914 | 3,416 | $0.00 |
85 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 15 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 1,126 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 3,315 | $0.00 |
| 82043 | 0% | 578 | $0.00 | |
| 74174 | 0% | 194 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 76 | $0.00 |
| 3044F | 0% | 700 | $0.00 | |
| 85652 | 0% | 321 | $0.00 | |
| 83735 | 0% | 271 | $0.00 | |
| 3075F | 0% | 339 | $0.00 | |
| 90656 | 0% | 171 | $0.00 | |
| 90677 | 0% | 90 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 360 | $0.00 |
| 81001 | 0% | 474 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 104 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 6,246 | $0.00 |
| 86901 | 0% | 25 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,338 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 25 | $0.00 |
| 96415 | 0% | 118 | $0.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 12 | $0.00 |
| 85027 | 0% | 1,034 | $0.00 | |
| 3074F | 0% | 1,045 | $0.00 | |
| 83550 | 0% | 341 | $0.00 | |
| 86706 | 0% | 101 | $0.00 | |
| 86160 | 0% | 12 | $0.00 | |
| 85730 | 0% | 95 | $0.00 | |
| 90686 | 0% | 122 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 115 | $0.00 |
| 82607 | 0% | 41 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 31 | $0.00 |
| 86780 | 0% | 41 | $0.00 | |
| 1111F | 0% | 230 | $0.00 | |
| 3080F | 0% | 36 | $0.00 | |
| 99441 | 0% | 12 | $0.00 | |
| 92227 | 0% | 41 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 12 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 15 | $0.00 |
| 92250 | 0% | 27 | $0.00 | |
| 86850 | 0% | 13 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 357 | $0.00 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 491 | $0.00 |
| 83540 | 0% | 350 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 159 | $0.00 |
| 80061 | Lipid panel | 0% | 1,597 | $0.00 |
| 82540 | 0% | 578 | $0.00 | |
| 86705 | 0% | 81 | $0.00 | |
| 3077F | 0% | 288 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 127 | $0.00 |
| 84100 | 0% | 314 | $0.00 | |
| 3046F | 0% | 155 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 422 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 3,399 | $0.00 |
| 85610 | 0% | 840 | $0.00 | |
| 82274 | 0% | 620 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 14 | $0.00 |
| 82570 | 0% | 183 | $0.00 | |
| 86703 | 0% | 329 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 15 | $0.00 |
| 82565 | 0% | 39 | $0.00 | |
| 3078F | 0% | 1,330 | $0.00 | |
| 90715 | 0% | 27 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 141 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 31 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 63 | $0.00 |
| 84439 | 0% | 262 | $0.00 | |
| 90750 | 0% | 81 | $0.00 | |
| 97161 | 0% | 27 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 93 | $0.00 |
| 81003 | 0% | 44 | $0.00 | |
| 90661 | 0% | 25 | $0.00 | |
| 3051F | 0% | 154 | $0.00 | |
| 76642 | 0% | 96 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 91 | $0.00 |
| 83970 | 0% | 52 | $0.00 | |
| 90653 | 0% | 36 | $0.00 | |
| 86900 | 0% | 25 | $0.00 | |
| 80076 | 0% | 30 | $0.00 | |
| 97803 | 0% | 12 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 26 | $0.00 |
| 86480 | 0% | 13 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 15 | $0.00 |
| 77062 | 0% | 119 | $0.00 | |
| 77080 | 0% | 12 | $0.00 | |
| 77066 | Tomosynthesis, mammo | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.